Stuart W. Yothers
Stuart represents clients across a broad technical spectrum, including wireless communications, semiconductor manufacturing and pharmaceuticals. His practice focuses primarily on patent litigation -- ranging from pre-suit investigations to trial. Stuart has served as the senior associate on numerous cases, efficiently managing all aspects of fact and expert discovery, claim construction, summary judgment and trial. He has argued in court numerous discovery matters, claim construction and summary judgment – having successfully argued summary judgment in a federal employment discrimination case. His 10-plus years of experience also include intellectual property due diligence, drafting intellectual property licenses, and pursuing patent protection for clients.
- Motorola Mobility, Inc. v. Microsoft Corporation, Civil Action No. 11-01408 (JLR) (W.D. Wa.),Microsoft Corporation v. Motorola, Inc. et al., Civil Action No. 10-01823 (JLR) (W.D. Wa.): represented Motorola in a multiple-patent dispute against Microsoft.
- Wi-LAN Inc. v. LG Electronics Mobilecomm U.S.A., Inc. et al., Civil Action No. 08-00247 (TJW) (E.D. Tx.): We represented LGEMU against Wi-LAN, a non-practicing entity, in a patent dispute involving IEEE 802.11 “WiFi” technology and CDMA2000 technology. The case was settled in January 2011.
- Entegris, Inc. v. Pall Corporation, Civil Action Nos. 03-10392, 06-10601 and 06-11494 (GAO) (D. Mass.): We represented Entegris in a multi-patent dispute against its chief competitor related to a mechanism for the quick connection of filters employed in clean room fabrication plants. The case was settled in January 2011.
- Steven D. Lukens v. Hillary Rodham Clinton, Civil Action No. 08-00243 (RMC) (D. D.C.): Stuart served as lead counsel in a disability-related employment discrimination action against the U.S. State Department’s Foreign Service. The case was settled in the spring of 2012.
- Cancer Research Tech. Ltd. and Schering Corp. v. Barr Laboratories, Inc. et al., Civil Action No. 07-457 (SLR) (D. Del.): After a seven-day ANDA trial involving the patent covering TEMODAR®, which is the leading chemotherapy drug used in the treatment of glioma (a type of brain cancer), the District Court prevented Barr from entering the market pending appeal; the Federal Circuit confirmed the enforceability of the patent-in-suit on appeal.
- Represented a medical device company before the Federal Circuit regarding the appeal of an interference proceeding related to pulse oximeter technology.
- New York Metro Super Lawyers - Rising Stars (2012)
- Empire State Counsel (2012)
- Speaker, "Ropes & Gray West Coast Lunchtime Legal Briefing Teleconference - Patent Litigation Before The ITC: Recent Developments And Trends," March 2013